Faculty of Medicine, The Chinese University of Hong Kong. Our commitment to innovation, creativity, ethics, compassion and professional development sets us apart from the rest.
News & Events

News14 December 2022
A joint HKU-CUHK study confirms smoking and obesity increase risk of severe COVID-19 by 65%-81%
Explore More
News12 December 2022
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

News8 December 2022
CU Medicine launches the Jockey Club “Confront Pain with Ease” Project Introducing innovative pain interventions and self-help measures to the community
Explore More
CUHK study supports continuation of renin-angiotensin system inhibitors (RASi) in patients with type 2 diabetes and advanced chronic kidney disease to reduce major cardiorenal complications
5 December 2022Most Read